Evidence map›Paper›PMID 34805160›Full record

ArticleFrontiers in cell and developmental biology2021

Identification of Key Genes Driving Tumor Associated Macrophage Migration and Polarization Based on Immune Fingerprints of Lung Adenocarcinoma.

Jing Wu, Jiawei Zhou, Qian Xu, Ruth Foley, Jianqiang Guo, Xin Zhang, Chang Tian, Min Mu, Yingru Xing, Yafeng Liu and 2 more

Abstract read
In one paragraph

Article in Frontiers in cell and developmental biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Jing WuSchool of Medicine, Anhui University of Science and Technology, Huainan, China.
Jiawei ZhouSchool of Medicine, Anhui University of Science and Technology, Huainan, China.
Qian XuThe Charles Institute of Dermatology, School of Medicine, University College Dublin, Dublin, Ireland.
Ruth FoleyThe Charles Institute of Dermatology, School of Medicine, University College Dublin, Dublin, Ireland.
Jianqiang GuoSchool of Medicine, Anhui University of Science and Technology, Huainan, China.
Xin ZhangSchool of Medicine, Anhui University of Science and Technology, Huainan, China.
Chang TianSchool of Medicine, Anhui University of Science and Technology, Huainan, China.
Min MuSchool of Medicine, Anhui University of Science and Technology, Huainan, China.
Yingru XingAffiliated Cancer Hospital, Anhui University of Science and Technology, Huainan, China.
Yafeng LiuSchool of Medicine, Anhui University of Science and Technology, Huainan, China.
Xueqin WangSchool of Medicine, Anhui University of Science and Technology, Huainan, China.
Dong HuSchool of Medicine, Anhui University of Science and Technology, Huainan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The identification of reliable indicators in the tumor microenvironment (TME) is critical for tumor prognosis. Tumor associated macrophages (TAMs) are the major component of non-tumor stromal cells in TME and have increasingly been recognized as a predictive biomarker for lung adenocarcinoma (LUAD) prognosis. Here, we report the development of a prognosis model for LUAD using three immune-related genes (IRGs) detected in The Cancer Genome Atlas (TCGA) which potentially regulate TAMs in TME. In 497 LUAD patients, higher immune scores conferred better overall survival (OS). We identified 93 hub IRGs out of 234 for further prognostic significance. Among them, three IRGs (BTK, Cd1c, and S100P) were proved to be closely correlated to the prognosis of patients with LUAD. Moreover, the immune risk score (IRS) based on the gene expression level of the three IRGs was an independent prognostic factor for OS. Higher IRS predicted lower OS, higher mortality and worse tumor stage. With a good predictive ability [area under the ROC curve (AUC) in TCGA = 0.701, AUC in GEO = 0.722], the IRS contributed to a good risk stratification ability of the nomogram. Immunologically, the three IRGs were related to M1 macrophages and NK cell subsets in TME. Interestingly, by characterizing these immune components

Indexed as

clinical prognosislung adenocarcinomamacrophage polarizationtumor infiltrating cellstumor microenvironment

Identifiers

PMID34805160
PMCPMC8600368

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.